慢性阻塞性肺疾病患者氧化应激和病情变化的研究  

Oxidative stress and change of pathogenetic condition in COPD patients

作　　者：朱迎伟[1] 娄源杰[1] 毛毅敏[1] 孙瑜霞[1] 王同生[1] 

机构地区：[1]河南科技大学第一附属医院呼吸内科,河南洛阳471000

出　　处：《临床荟萃》2010年第21期1874-1877,共4页Clinical Focus

摘　　要：目的探讨慢性阻塞性肺疾病(COPD)患者急性加重期及病情缓解后氧化应激程度。方法选取33例慢性阻塞性肺疾病急性加重期(AECOPD)患者(实验组)及31例健康体检者(对照组)采用菲罗啉比色法检测血浆总抗氧化能力(TAC)、硫代巴比妥酸比色法检测血浆丙二醛(MDA)含量、改良Hafeman直接测定法(DNTB)检测血浆谷胱甘肽过氧化物酶(GSH-PX)活力,同时进行动脉血气检测及功能性呼吸困难评分。结果实验组病情缓解后动脉血氧分压(PaO2)(62.32±8.50)mmHg(1 mmHg=0.133 kPa)较急性加重期(49.06±7.64)mmHg升高(P<0.01);动脉血二氧化碳分压(PaCO2)(41.81±7.23)mmHg较急性加重期(45.63±7.81)mmHg降低(P<0.05)。实验组病情缓解后功能性呼吸困难评分(MMRC)(1.55±0.61)较急性加重期(2.61±0.68)显著好转(P<0.01)。实验组病情缓解后血浆TAC、GSH-PX均较急性加重期明显升高(6.77±1.28)kU/L vs(5.52±1.15)kU/L、(168.17±43.66)kU/L vs(132.27±39.45)kU/L明显升高(P<0.01),但显著低于对照组(7.76±1.41)kU/L、(197.92±53.28)kU/L(均P<0.01)。实验组病情缓解后血浆MDA(5.43±1.86)μmol/L较急性加重期(7.28±2.03)μmol/L明显降低(P<0.01),但显著高于对照组(3.89±1.46)μmol/L(均P<0.01)。实验组急性加重期及病情缓解后血浆TAC均与MDA呈负相关(r=-0.587、r=-0.450,P<0.01或<0.05)。实验组急性加重期及病情缓解后血浆TAC均与GSH-PX及PaO2呈正相关(r分别0.556、0.583和0.433、0.396,均P<0.05或<0.01)。实验组急性加重期及病情缓解后血浆TAC与PaCO2无明显相关(r分别为0.230、-0.225,均P>0.05);实验组急性加重期及病情缓解后血浆MDA与PaO2呈负相关(r分别为-0.463、-0.411,均P<0.05)、与PaCO2无明显相关(r分别为0.198、-0.232,均P>0.05)。结论 AECOPD患者体内氧化/抗氧化失衡,存在氧化应激;AECOPD患者加重缓解后,氧化应激损伤明显减轻;AECOPD患者氧化损伤与缺氧密切相关。Objective To explore the levels of the oxidative stress in chronic obstructive pulmonary disease（COPD） patients in acute exacerbation（AECOPD） and after remission.Methods The total antioxidative capacity（TAC） in blood plasma of 33 patients with COPD in acute exacerbation after remission and respectively and in 31 healthy persons were measured by o-phenanthroline colorimetric analysis.The contents of malondialdehyde（MDA） in blood plasma were measured by thiobarbituricacid colorimetric analysis.The capacity of glutathion peroxidase（GSH-PX） in blood plasma was measured by the method of DNTB.The respiratory functions were measured by arterial blood gas testing and modified medical research council dyspnea scale respectively.Results The indexes associated with respiratory function：the level of PaO2 in AECOPD patients after remission（62.32±8.50） mmHg was higher than than in acute exacerbation（49.06±7.64） mmHg（P0.01）,the level of PaCO2 in AECOPD patients after remission（41.81±7.23） mmHg was lower than that in acute exacerbation（45.63±7.81） mmHg（P0.05）.The dyspnea scale in AECOPD patients after remission（1.55±0.61） was lower than that in acute exacerbation（2.61±0.68）（P0.01）.The degree of oxidative stress：the level of TAC in the blood plasma in AECOPD patients after remission（6.77±1.28） kU/L was significantly higher than that in acute exacerbation（5.52±1.15） kU/L（P0.01）,and they were all significantly lower than that in the healthy controls（7.76±1.41） kU/L（all P0.01） respectively.The content of MDA in the blood plasma in AECOPD patients after remission（5.43±1.86） μmol/L was significantly lower than that in acute exacerbation（7.28±2.03） μmol/L（P0.01）,and they were all significantly higher than those in the healthy controls（3.89±1.46） μmol/L（all P0.01） respectively.The level of GSH-PX in the blood plasma in AECOPD patients after remission（168.17±43.66） kU/L was significantly higher than that in acute exacer

关 键 词：肺疾病 慢性阻塞性 丙二醛 谷胱甘肽过氧化物酶 血气监测 经皮 

分 类 号：R563[医药卫生—呼吸系统]